| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cytochrome P450 11B1, mitochondrial |
|---|
| Ligand | BDBM473913 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Inhibition of Cortisol Synthesis |
|---|
| IC50 | 27000000±n/a nM |
|---|
| Citation |  Balestra, M; Burke, J; Chen, Z; Cogan, D; Lord, J; Marshall, DR; McKibben, BP; Meyers, KM; Zhang, Y Bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases and fibrotic diseases US Patent US10858342 Publication Date 12/8/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cytochrome P450 11B1, mitochondrial |
|---|
| Name: | Cytochrome P450 11B1, mitochondrial |
|---|
| Synonyms: | C11B1_HUMAN | CYP11B1 | CYPXIB1 | Cytochrome P450 11B, mitochondrial precursor | Cytochrome P450 11B1 | Cytochrome P450 11B1 (CYP11B1) | Cytochrome P450 11B1, mitochondrial | S11BH |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 57591.44 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P15538 |
|---|
| Residue: | 503 |
|---|
| Sequence: | MALRAKAEVCMAVPWLSLQRAQALGTRAARVPRTVLPFEAMPRRPGNRWLRLLQIWREQG
YEDLHLEVHQTFQELGPIFRYDLGGAGMVCVMLPEDVEKLQQVDSLHPHRMSLEPWVAYR
QHRGHKCGVFLLNGPEWRFNRLRLNPEVLSPNAVQRFLPMVDAVARDFSQALKKKVLQNA
RGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFM
PRSLSRWTSPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFSRPQQYTSIVAELLLNAELS
PDAIKANSMELTAGSVDTTVFPLLMTLFELARNPNVQQALRQESLAAAASISEHPQKATT
ELPLLRAALKETLRLYPVGLFLERVASSDLVLQNYHIPAGTLVRVFLYSLGRNPALFPRP
ERYNPQRWLDIRGSGRNFYHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHLQVETLTQED
IKMVYSFILRPSMFPLLTFRAIN
|
|
|
|---|
| BDBM473913 |
|---|
| n/a |
|---|
| Name | BDBM473913 |
|---|
| Synonyms: | 6,6-Dimethyl-3-(3- trifluoromethyl-phenyl)- 3,5,6,7-tetrahydro- benzoimidazol-4-one | US10858342, Compound C-ABZ |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H15F3N2O |
|---|
| Mol. Mass. | 308.2983 |
|---|
| SMILES | CC1(C)Cc2ncn(c2C(=O)C1)-c1cccc(c1)C(F)(F)F |
|---|
| Structure | 
|
|---|
Search and Browse
